Adagene Inc. (ADAG) shareholders
Close on Nov 17, 2026Market cap $87.66MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| HAN 2020 Irrevocable Trust Joint filing with Peter Luo (7.09%) | 9,390,439 | 11.20% | 13D (active) amendment | Jun 5, 2026 |
| Janus Henderson Group PLC | 6,666,666 | 10.10% | 13G (passive) | Apr 30, 2026 |
| Smith Vincent C Joint filing with The Vincent C. Smith, Jr. 2025 Annuity Trust (6.10%) | 5,095,351 | 8.70% | 13G (passive) amendment | Dec 31, 2025 |
| FIL Limited Joint filing with Pandanus Partners, L.P. (7.80%), Pandanus Associates, Inc. (7.80%) | 4,093,498 | 7.80% | 13G (passive) amendment | Dec 31, 2024 |
| OT Management, LLC Joint filing with Nichola Eliovits (8.10%) | 3,567,653 | 8.10% | 13G (passive) amendment | Sep 6, 2024 |
| OT Healthcare Fund I, LLC | 3,277,814 | 5.90% | 13G (passive) | Sep 6, 2024 |
| Panacea Venture Healthcare Fund II GP Company, Ltd. Joint filing with Panacea Venture Healthcare Fund II, L.P. (5.50%), Panacea Innovation Limited (5.50%) and 1 more | 3,037,500 | 5.50% | 13G (passive) amendment | Dec 31, 2024 |
| Chernett Jorey | 2,389,060 | 5.10% | 13G (passive) | Mar 16, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ADAG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 6,666,666 | 11.26% | $28.10M | New | 0.01% |
| Siren, L.L.C. | 2,666,666 | 4.50% | $11.20M | New | 0.23% |
| Deerfield Management Company, L.P. (Series C) | 2,666,666 | 4.50% | $11.20M | New | 0.12% |
| Ameriprise Financial Inc | 1,716,711 | 2.90% | $7.21M | +1,108,808 | 0.00% |
| HSG Holding Ltd | 1,343,364 | 2.27% | $5.64M | – | 0.45% |
| Squadron Capital Management LLC | 1,250,000 | 2.11% | $5.25M | New | 1.63% |
| Dauntless Investment Group, LLC | 537,230 | 0.91% | $2.26M | +502,455 | 1.77% |
| Citadel Advisors LLC | 506,934 | 0.86% | $2.13M | New | 0.00% |
| Exome Asset Management LLC | 488,293 | 0.82% | $2.05M | −248,552 | 1.27% |
| Birchview Capital, LP | 240,000 | 0.41% | $1.01M | New | 0.47% |
| Moneta Group Investment Advisors LLC | 200,000 | 0.34% | $840.00K | New | 0.01% |
| Pathstone Holdings, LLC | 199,610 | 0.34% | $838.36K | New | 0.00% |
| Renaissance Technologies LLC | 146,500 | 0.25% | $615.30K | +111,967 | 0.00% |
| UBS Group AG | 124,063 | 0.21% | $521.07K | +120,061 | 0.00% |
| Goldman Sachs Group Inc | 105,598 | 0.18% | $443.51K | New | 0.00% |
| Quadrature Capital Ltd | 80,487 | 0.14% | $338.05K | +68,870 | 0.00% |
| Marshall Wace, Llp | 69,100 | 0.12% | $290.22K | New | 0.00% |
| Invesco Ltd. | 42,945 | 0.07% | $180.37K | −4,179 | 0.00% |
| SmartHarvest Portfolios, LLC | 41,694 | 0.07% | $175.12K | +1,382 | 0.06% |
| Kamunting Street Capital Management, L.P. | 38,070 | 0.06% | $160.00K | – | 0.09% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 36 | 19M | 32.5% | 17 / 10 | 6 / 5 | 17M | 0M |
| Q1 2026 | 25 | 3M | 5.6% | 11 / 3 | 6 / 3 | 1M | 1M |
| Q4 2025 | 17 | 3M | 5.2% | 4 / 4 | 3 / 4 | 1M | 4M |
| Q3 2025 | 17 | 6M | 9.7% | 3 / 2 | 6 / 1 | 0M | 0M |
| Q2 2025 | 15 | 6M | 10.3% | 3 / 3 | 3 / 2 | 0M | 2M |
| Q1 2025 | 14 | 8M | 12.9% | 2 / 1 | 6 / 3 | 0M | 3M |
| Q4 2024 | 15 | 10M | 17.6% | 4 / 5 | 1 / 1 | 4M | 1M |
| Q3 2024 | 13 | 11M | 19.3% | 1 / 2 | 3 / 2 | 0M | 0M |
| Q2 2024 | 14 | 11M | 18.9% | 2 / 1 | 5 / 5 | 0M | 1M |
| Q1 2024 | 17 | 12M | 21.1% | 6 / 3 | 2 / 0 | 5M | 0M |
| Q4 2023 | 11 | 7M | 12.3% | 2 / 1 | 1 / 1 | 4M | 1M |
| Q3 2023 | 10 | 4M | 6.9% | 1 / 2 | 1 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
2 funds held ADAG in Q2 2026, 82% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ADAG | Value | % of fund | As of |
|---|---|---|---|---|---|
| Invesco Golden Dragon China ETF | 42,285 | 0.07% | $158.57K | 0.16% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 10,309 | 0.02% | $40.93K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Man Kin Tam | Chief Financial Officer, Director | 12,000 | 0.02% | Sep 25, 2026 |
| Peter Luo | Chief Executive Officer, Director | 194,556 | 0.33% | Sep 17, 2026 |
| Chunfang Gu | Executive Director of Finance | 15,625 | 0.03% | Oct 2, 2026 |
| Mickael Yannick Chane-Du | Chief Strategy Officer | 467,525 | 0.79% | Mar 18, 2026 |
| Qinghai Zhao | Chief Manufacturing Officer | 37,500 | 0.06% | Mar 18, 2026 |
| Ling Zhou | ED of Human Resources | 2,969 | 0.01% | Mar 18, 2026 |
| Cuong V. Do | Director | 2,000 | 0.00% | Aug 18, 2026 |
| Andy Yiu Leung Cheung | Director | – | – | Aug 17, 2026 |
| Li Zhu | Director | – | – | Aug 17, 2026 |
| Ulf Grawunder | Director | 25,000 | 0.04% | Aug 14, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Man Kin Tam Chief Financial Officer, Director | Sep 23, 2026 | Buy | +2,000 | $3.00 | $6.00K | 12,000 |
| Peter Luo Chief Executive Officer, Director | Sep 16, 2026 | Buy | +20,290 | $3.15 | $63.91K | 88,535 |
| Cuong V. Do Director | Aug 14, 2026 | Buy | +2,000 | $3.75 | $7.50K | 2,000 |
| Peter Luo Chief Executive Officer, Director | Aug 5, 2026 | Buy | +279 | $3.65 | $1.02K | 68,245 |
| Peter Luo Chief Executive Officer, Director | Aug 4, 2026 | Buy | +22,966 | $3.65 | $83.83K | 67,966 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Adagene's stock actually held short. Settlement fails (shares not delivered on time) peaked at 11,772 shares on Oct 7, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Adagene Inc. Officer | Aug 20, 2026 | 131,000 | $517.45K | Aug 21, 2026 | VESTING OF OPTIONS GRANTED PURSUANT TO ISSUER ESOP PLAN |
| Chunfang Gu Officer | Aug 19, 2026 | 131,000 | $517.45K | Aug 20, 2026 | VESTING OF OPTIONS GRANTED PURSUANT TO ISSUER ESOP PLAN |
See a number that looks wrong?